| MERCK & CO. INC. |
| USA |
| Gesundheit |
| US58933Y1055 / A0YD8Q |
| 6MK (Frankfurt) / MRK (NYSE) |
| FRA:6MK, ETR:6MK, 6MK:GR, NYSE:MRK |
| https://www.merck.com/ |
|
Merck & Co., Inc. operates as a leading healthcare company worldwide, focusing on human health pharmaceuticals, vaccines, and animal health products. Its portfolio includes blockbuster drugs like Keytruda for immuno-oncology, Gardasil for human papil..
>Volltext.. |
| 236356.52 Mio. EUR |
| 236356.52 Mio. EUR |
| 55964.34 Mio. EUR |
| - |
| 7623.39 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| -3.71% |
| -52.01% |
| 2.85 EUR |
| 2.96% |
| 3.07% |
| 16.03.26 - 0.73703504€ 15.12.25 - 0.72369003€ >weitere anzeigen... |
| - |
| MERCK & CO, MERCK&CO, MERCK CO, MERCKCO, MRK |
| 03.05.26 |
|
||||
|
||||
|